Ardelyx Inc (ARDX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $3.45 (+2.07%), Market cap $1.50B, 52-week low–high $3.55 ~ $7.99.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for Ardelyx Inc are updated in real time on BlackAll Trade.
Ardelyx Inc trades at $3.45 (+2.07%). Real-time quotes and charts are available on BlackAll Trade.
Ardelyx Inc has a market cap of about $1.50B.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule t